Anna Koo, M.D.
| Appointed: |
1984 |
| Gender: |
Female |
| Languages: |
Chinese
English |
Hematologic Oncology and Blood Disorders
Rheumatologic and Immunologic Disease
Professional Highlights
- Past President, American Society for Apheresis, 2003-2004
- Board Member, International Society for Apheresis, 2001-2007
- Certified, American Board of Rheumatology, 1988
- Certified, American Board of Internal Medicine, 1982
- Editorial Board, Therapeutic Apheresis and Dialysis, 2001-Present
Education & Fellowships
| Medical School: | UMDNJ - New Jersey Medical School, Newark, NJ |
|
| Internship: | Cleveland Clinic, Internal Medicine, Cleveland, OH |
| Residency: | Cleveland Clinic, Internal Medicine, Cleveland, OH |
| Fellowship: | Cleveland Clinic, Rheumatology-Immunology Research Fellowship, Cleveland, OH |
| Fellowship: | Cleveland Clinic, Rheumatology, Cleveland, OH |
| Other Education: | (Undergraduate) Douglass College, New Brunswick, NJ |
Certifications
Rheumatology
Internal Medicine
Specialty Interests
General rheumatology, therapeutic apheresis.
Professional Memberships
- American Society for Apheresis
- International Society for Apheresis
- American College of Rheumatology
- American College of Physicians
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/30/2008, Dr. Koo has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
